Henry H. Armstrong Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,106
| Closed | -$356K | – | 59 |
|
|
2024
Q3 | $356K | Hold |
1,106
| – | – | 0.03% | 53 |
|
|
2024
Q2 | $346K | Hold |
1,106
| – | – | 0.03% | 51 |
|
|
2024
Q1 | $314K | Buy |
1,106
+235
| +27% | +$68.8K | 0.03% | 49 |
|
|
2023
Q4 | $251K | Buy |
871
+1
| +0.1% | +$272 | 0.03% | 50 |
|
|
2023
Q3 | $234K | Buy |
+870
| New | +$217K | 0.03% | 52 |
|
|
2023
Q2 | – | Sell |
-871
| Closed | -$211K | – | 58 |
|
|
2023
Q1 | $211K | Hold |
871
| – | – | 0.03% | 57 |
|
|
2022
Q4 | $229K | Buy |
+871
| New | +$233K | 0.03% | 59 |
|
|
2022
Q3 | – | Sell |
-896
| Closed | -$218K | – | 61 |
|
|
2022
Q2 | $218K | Hold |
896
| – | – | 0.03% | 61 |
|
|
2022
Q1 | $217K | Sell |
896
-690
| -44% | -$159K | 0.02% | 61 |
|
|
2021
Q4 | $357K | Buy |
1,586
+74
| +5% | +$15.6K | 0.04% | 52 |
|
|
2021
Q3 | $322K | Hold |
1,512
| – | – | 0.04% | 53 |
|
|
2021
Q2 | $369K | Sell |
1,512
-50
| -3% | -$12.3K | 0.04% | 50 |
|
|
2021
Q1 | $389K | Hold |
1,562
| – | – | 0.05% | 50 |
|
|
2020
Q4 | $359K | Sell |
1,562
-1,279
| -45% | -$295K | 0.05% | 50 |
|
|
2020
Q3 | $722K | Hold |
2,841
| – | – | 0.1% | 40 |
|
|
2020
Q2 | $670K | Hold |
2,841
| – | – | 0.1% | 40 |
|
|
2020
Q1 | $576K | Hold |
2,841
| – | – | 0.1% | 41 |
|
|
2019
Q4 | $685K | Sell |
2,841
-130
| -4% | -$28.7K | 0.1% | 44 |
|
|
2019
Q3 | $575K | Hold |
2,971
| – | – | 0.09% | 33 |
|
|
2019
Q2 | $547 | Hold |
2,971
| – | – | 0.07% | 36 |
|
|
2019
Q1 | $564K | Hold |
2,971
| – | – | 0.09% | 37 |
|
|
2018
Q4 | $578K | Hold |
2,971
| – | – | 0.09% | 36 |
|
|
2018
Q3 | $616K | Hold |
2,971
| – | – | 0.09% | 38 |
|
|
2018
Q2 | $548K | Hold |
2,971
| – | – | 0.09% | 39 |
|
|
2018
Q1 | $520K | Sell |
2,971
-222
| -7% | -$40.8K | 0.09% | 38 |
|
|
2017
Q4 | $555K | Sell |
3,193
-55
| -2% | -$9.73K | 0.09% | 38 |
|
|
2017
Q3 | $606K | Hold |
3,248
| – | – | 0.11% | 37 |
|
|
2017
Q2 | $559K | Hold |
3,248
| – | – | 0.11% | 36 |
|
|
2017
Q1 | $533K | Hold |
3,248
| – | – | 0.1% | 38 |
|
|
2016
Q4 | $475K | Sell |
3,248
-1,035
| -24% | -$156K | 0.1% | 37 |
|
|
2016
Q3 | $714K | Buy |
4,283
+2,035
| +91% | +$344K | 0.14% | 32 |
|
|
2016
Q2 | $342K | Hold |
2,248
| – | – | 0.07% | 44 |
|
|
2016
Q1 | $337K | Hold |
2,248
| – | – | 0.07% | 38 |
|
|
2015
Q4 | $365K | Buy |
2,248
+100
| +5% | +$15.7K | 0.07% | 39 |
|
|
2015
Q3 | $297K | Buy |
2,148
+63
| +3% | +$9.93K | 0.06% | 36 |
|
|
2015
Q2 | $320K | Hold |
2,085
| – | – | 0.08% | 32 |
|
|
2015
Q1 | $333K | Sell |
2,085
-38
| -2% | -$5.99K | 0.07% | 32 |
|
|
2014
Q4 | $338K | Hold |
2,123
| – | – | 0.07% | 31 |
|
|
2014
Q3 | $298K | Hold |
2,123
| – | – | 0.07% | 31 |
|
|
2014
Q2 | $251K | Buy |
2,123
+38
| +2% | +$4.4K | 0.06% | 36 |
|
|
2014
Q1 | $257K | Buy |
+2,085
| New | +$253K | 0.06% | 37 |
|
Other funds holding AMGN
Henry H. Armstrong Associates's AMGN Position: Q4 2024 in Review
Henry H. Armstrong Associates sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,106 shares — an estimated $356K sold.
Henry H. Armstrong Associates first reported a position in AMGN in Q1 2014 and held it in 41 quarters. The position peaked at $722K in Q3 2020. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Henry H. Armstrong Associates reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Henry H. Armstrong Associates sold 1,106 Amgen shares in Q4 2024, an estimated $356K.
- Henry H. Armstrong Associates first reported a position in Amgen in Q1 2014 and held it in 41 quarters.
- Henry H. Armstrong Associates's Amgen position peaked at $722K in Q3 2020.
- 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Henry H. Armstrong Associates's 13F filing for Q4 2024, filed 13 Jan 2025.